Funded Grants

PI Name PI Organization Title Grant Number Initiative Program Official
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

 Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

 Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

 Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

 Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

 Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

 Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

 Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Hitchins, Megan P

Cedars-Sinai Medical Center
United States

 Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age 5R01CA252042-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Hoffman, Amy Jude

University Of Nebraska Medical Center
United States

 Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients 5R01CA205025-06
Hofseth, Lorne J

University Of South Carolina At Columbia
United States

 Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer 3R01CA246809-05S1 Marjorie Perloff, M.D.